| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09344309 |
| PharmacoGx | BRD-K09344309 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LANCL3 | CTRPv2 | pan-cancer | AAC | 0.41 | 8e-09 |
| mRNA | OR4A16 | CTRPv2 | pan-cancer | AAC | 0.46 | 9e-09 |
| mRNA | NKX2-6 | CTRPv2 | pan-cancer | AAC | 0.5 | 1e-07 |
| mRNA | TAS2R16 | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-07 |
| mRNA | ACTL7A | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-07 |
| mRNA | C11orf87 | CTRPv2 | pan-cancer | AAC | 0.4 | 6e-07 |
| mRNA | CLEC1B | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-06 |
| mRNA | TMEM57 | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-06 |
| mRNA | YOD1 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-06 |
| mRNA | OR10G4 | CTRPv2 | pan-cancer | AAC | 0.37 | 5e-06 |
